Contraceptive Technology Update
RSSArticles
-
Intrauterine Device Use Linked With Decrease in Cervical Cancer Incidence
Results of a just-published systematic review indicate that in women who used an intrauterine device, the incidence of cervical cancer was one-third lower.
-
Time to Update Your Knowledge of Long-Acting Reversible Contraceptives
Practice bulletin says intrauterine, implant options are safe and effective for almost all women.
-
Science Focuses on Mycoplasma genitalium
Mycoplasma genitalium, a sexually transmitted infection, is a major cause of urethritis in men and is associated with cervicitis, pelvic inflammatory disease, preterm birth, and spontaneous abortion in women.
-
New Study Points to Long-term Effectiveness of 9-Valent HPV Vaccine
Vaccine could prevent 90% of cervical cancer cases worldwide.
-
HIV Pre-exposure Prophylaxis for Adolescents: A Health Equity and Reproductive Justice Issue
Access to HIV pre-exposure prophylaxis is not just a public health issue, but equally important, an equity and justice issue.
-
Low Rates of Adherence to PID Guidance Found in Emergency Departments
Research analyzing trends in the nation’s emergency departments indicates low rates of HIV and syphilis screening among teens diagnosed with pelvic inflammatory disease, despite the high risk for such infections. Data also suggest low rates of adherence to national treatment guidelines.
-
Clinician Alert: STIs Hit High-water Mark
More than 2 million cases of chlamydia, gonorrhea, and syphilis were reported in the United States in 2016, the highest number ever, according to the latest surveillance from the Centers for Disease Control and Prevention.
-
Vending Machines Expand Options for College Health Emergency Contraception
While age restrictions on levonorgestrel emergency contraceptive pills (ECPs) were removed in 2013, access to pills often is tricky, even for college-age students. Now Stanford University and University of California locations in Santa Barbara and Davis are among the latest campuses that have installed vending machines stocked with ECPs.
-
U.S. MEC Updates Contraceptive Information for Women With HIV
The Centers for Disease Control and Prevention is revising its recommendation on the use of the progestin-only contraception injection depot medroxyprogesterone acetate (DMPA) by women at high risk for HIV from Category 1 (no restriction) to Category 2 (benefits outweigh theoretical or proven risks).
-
Task Force Issues Cervical Cancer Screening Guidance: What Changes Can Clinicians Expect?
Ages 30-65: Cervical cytology every three years or HPV testing every five years.